128 related articles for article (PubMed ID: 15354969)
1. The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in hemodialyzed patients with chronic renal failure.
Bronisz M; Rość D; Bronisz A; Manitius J; Nartowicz E
Ren Fail; 2004 May; 26(3):223-9. PubMed ID: 15354969
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
Malyszko J; Malyszko JS; Mysliwiec M
Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
[TBL] [Abstract][Full Text] [Related]
5. Enhanced fibrinolytic activity during the course of hemodialysis.
Nakamura Y; Tomura S; Tachibana K; Chida Y; Marumo F
Clin Nephrol; 1992 Aug; 38(2):90-6. PubMed ID: 1387598
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
7. Relationship between elevation in the plasma concentration of elastase-alpha 1 proteinase inhibitor complex (E-alpha 1 PI) and haemostatic parameters during haemodialysis.
Yamazaki M; Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Aoshima K; Sato T; Tsugawa Y
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):5-10. PubMed ID: 7795153
[TBL] [Abstract][Full Text] [Related]
8. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
[TBL] [Abstract][Full Text] [Related]
10. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
[TBL] [Abstract][Full Text] [Related]
11. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis.
Deguchi K; Izumi K; Noguchi M; Yuwasaki E; Suzuki H; Mori Y; Deguchi A; Ohkubo I; Tsuda M; Wada H
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):140-6. PubMed ID: 2741646
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical and laboratory parameters in patients with end-stage renal failure in the outcome of chronic glomerulonephritis and patients with end-stage renal failure in the outcome of other diseases.
Popova JA; Yadrihinskaya VN; Krylova MI; Sleptsovа SS; Borisovа NV
Wiad Lek; 2016; 69(6):739-741. PubMed ID: 28214807
[TBL] [Abstract][Full Text] [Related]
14. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
Pawlak K; Buraczewska-Buczko A; Mysliwiec M; Pawlak D
Am J Med Sci; 2010 Jan; 339(1):5-9. PubMed ID: 19926968
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders.
Opatrný K; Zemanová P; Mares J; Vít L; Opatrná S; Sefrna F; Hejda V; Tomsů M; Eiselt J; Massry SG
Am J Nephrol; 2002; 22(5-6):429-36. PubMed ID: 12381940
[TBL] [Abstract][Full Text] [Related]
16. Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patients.
Małyszko J; Łebkowska U; Małyszko JS; Myśliwiec M
Med Sci Monit; 2009 Dec; 15(12):CR644-9. PubMed ID: 19946236
[TBL] [Abstract][Full Text] [Related]
17. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis.
Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J
Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis disorders in chronic renal failure.
Opatrný K
Kidney Int Suppl; 1997 Nov; 62():S87-9. PubMed ID: 9350690
[TBL] [Abstract][Full Text] [Related]
19. [Hemostatic disturbances in chronic myeloid leukemia].
Rość D; Kremplewska-Nalezyta E; Gadomska G; Bielis L
Wiad Lek; 2007; 60(3-4):138-42. PubMed ID: 17726865
[TBL] [Abstract][Full Text] [Related]
20. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
